blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2488640

EP2488640 - ANTIPROLIFERATIVE AGENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.2019
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  24.08.2018
FormerGrant of patent is intended
Status updated on  10.04.2018
FormerExamination is in progress
Status updated on  16.12.2016
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
[2018/39]
Former [2012/34]For all designated states
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
Inventor(s)01 / TAN, Nguan, Soon
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
02 / CHONG, Han, Chung
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
03 / TAN, Ming, Jie
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
04 / HUANG, Royston
Nanyang Technological University
50 Nanyang Avenue
Singapore 639798 / SG
 [2012/34]
Representative(s)Mader, Joachim, et al
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
[N/P]
Former [2018/39]Hess, Peter K. G.
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
Former [2012/34]Ratcliffe, Susan Margaret
Acredian IP
27 Springhill
Stroud
Gloucestershire GL5 1TN / GB
Application number, filing date10823705.814.10.2010
[2018/39]
WO2010SG00392
Priority number, dateUS20090251485P14.10.2009         Original published format: US 251485 P
[2012/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011046515
Date:21.04.2011
Language:EN
[2011/16]
Type: A1 Application with search report 
No.:EP2488640
Date:22.08.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 21.04.2011 takes the place of the publication of the European patent application.
[2012/34]
Type: B1 Patent specification 
No.:EP2488640
Date:26.09.2018
Language:EN
[2018/39]
Search report(s)International search report - published on:AU21.04.2011
(Supplementary) European search report - dispatched on:EP04.12.2013
ClassificationIPC:C12N15/00, C12N15/113, C07K16/00, A61P35/00, A61K31/7088, A61K39/395
[2012/34]
CPC:
A61P35/00 (EP); C07K16/22 (EP,US); C12N15/1136 (EP,US);
C12N15/1138 (EP,US); A61K2039/505 (EP,US); C12N2310/14 (EP,US);
C12N2310/531 (EP,US); C12N2330/50 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/34]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANTIPROLIFERATIONSMITTEL[2012/34]
English:ANTIPROLIFERATIVE AGENT[2012/34]
French:AGENT ANTIPROLIFÉRATIF[2012/34]
Entry into regional phase28.03.2012National basic fee paid 
28.03.2012Search fee paid 
28.03.2012Designation fee(s) paid 
28.03.2012Examination fee paid 
Examination procedure12.08.2011Request for preliminary examination filed
International Preliminary Examining Authority: AU
28.03.2012Examination requested  [2012/34]
13.06.2014Amendment by applicant (claims and/or description)
24.08.2016Despatch of a communication from the examining division (Time limit: M06)
24.01.2017Reply to a communication from the examining division
07.06.2017Despatch of a communication from the examining division (Time limit: M04)
17.10.2017Reply to a communication from the examining division
11.04.2018Communication of intention to grant the patent
13.08.2018Fee for grant paid
13.08.2018Fee for publishing/printing paid
13.08.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.08.2016
Opposition(s)27.06.2019No opposition filed within time limit [2019/36]
Fees paidRenewal fee
11.10.2012Renewal fee patent year 03
14.10.2013Renewal fee patent year 04
14.10.2014Renewal fee patent year 05
12.10.2015Renewal fee patent year 06
11.10.2016Renewal fee patent year 07
11.10.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.10.2010
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
MK26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
IE14.10.2018
LU14.10.2018
MT14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
[2020/31]
Former [2020/30]HU14.10.2010
AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
IE14.10.2018
LU14.10.2018
MT14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2020/17]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
IE14.10.2018
LU14.10.2018
MT14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2020/08]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
IE14.10.2018
LU14.10.2018
MT14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/50]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
IE14.10.2018
LU14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/48]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
IE14.10.2018
LU14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/38]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
LU14.10.2018
BE31.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/34]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
LU14.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/33]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
LU14.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/30]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
LU14.10.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/26]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/23]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/22]AL26.09.2018
CZ26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/21]AL26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/20]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/12]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/11]FI26.09.2018
HR26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/10]FI26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/08]FI26.09.2018
LT26.09.2018
NO26.12.2018
Former [2019/07]LT26.09.2018
Documents cited:Search[XYI]WO2006014729  (GENENTECH INC [US], et al) [X] 1-3,5-8,10,11 * claim - * * paragraph [0194] * * the whole document * [Y] 4,9 [I] 12-14;
 [Y]WO2006074228  (LEXICON GENETICS INC [US], et al) [Y] 4,9 * page 97 - page 98 * * page 102 - page 103 *
International search[X]WO2006014678  (GENENTECH INC [US], et al);
 [X]WO2006014729  (GENENTECH INC [US], et al);
 [X]WO2006074228  (LEXICON GENETICS INC [US], et al);
 [X]US2006019284  (HUANG FEI [US], et al);
 [XP]  - MA T ET AL., "Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma'", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20100726), pages 1 - 6, XP008154839

DOI:   http://dx.doi.org/10.1073/pnas.1001065107
ExaminationWO2006044779
    - ZHANG Z ET AL, "Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells", CANCER LETTERS, NEW YORK, NY, US, vol. 267, no. 1, doi:10.1016/J.CANLET.2008.03.010, ISSN 0304-3835, (20080818), pages 106 - 115, (20080422), XP022797047

DOI:   http://dx.doi.org/10.1016/j.canlet.2008.03.010
by applicantUS4816567
 US5545807
 US5545806
 US5569825
 US5625126
 US5633425
 US5661016
 US4676980
 WO9100360
 WO9200373
 EP0003089
 US6667371
 US6613355
 US6596296
 US6413536
 US5968543
 US4079038
 US4093709
 US4131648
 US4138344
 US4180646
 US4304767
 US4946931
    - Immunology Methods Manual, Academic Press, (19970000), vol. 2
    - Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, (19880000), pages 78 - 87
    - Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, (19880000), pages 55 - 120
    - KOHLER; MILSTEIN, Nature, (19750000), vol. 256, page 495
    - KOZBOR, J., Immunol, (19840000), vol. 133, page 3001
    - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
    - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327
    - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536
    - HOOGENBOOM; WINTER, J., Mol. Biol., (19910000), vol. 227, page 381
    - MARKS et al., J. Mol. Biol., (19910000), vol. 222, page 581
    - COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77
    - BOEMER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95
    - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
    - LONBERG et al., Nature, (19940000), vol. 368, pages 856 - 859
    - MORRISON, Nature, (19940000), vol. 368, pages 812 - 813
    - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 845 - 851
    - NEUBERGER, Nature Biotechnology, (19960000), vol. 14, page 826
    - LONBERG; HUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93
    - MILSTEIN; CUELLO, Nature, (19830000), vol. 305, pages 537 - 539
    - MORDENTI; RESCIGNO, Pharmaceutical Research, (19920000), vol. 9, pages 17 - 25
    - MORENTI et al., Pharmaceutical Research, (19910000), vol. 8, pages 1351 - 1359
    - "The use of interspecies scaling in toxicokinetics", MORDENTI; CHAPPELL et al., Toxicokinetics and New Drug Development, Pergamon Press, (19890000), pages 42 - 96
    - CHONG, H.C.; TAN, M.J.; PHILIPPE, V.; TAN, S.H.; TAN, C.K.; KU, C.W.; GOH, Y.Y.; WAHLI, W.; MICHALIK, L.; TAN, N.S., "Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing", J Cell Biol, (20090000), vol. 184, pages 817 - 831
    - DESAI, U.; LEE, E.C.; CHUNG, K.; GAO, C.; GAY, J.; KEY, B.; HANSEN, G.; MACHAJEWSKI, D.; PLATT, K.A.; SANDS, A.T. et al., "Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice", Proc Natl Acad Sci U S A, (20070000), vol. 104, doi:doi:10.1073/pnas.0705041104, pages 11766 - 11771, XP008130955

DOI:   http://dx.doi.org/10.1073/pnas.0705041104
    - DI POI, N.; TAN, N.S.; MICHALIK, L.; WAHLI, W.; DESVERGGNE, B., Mol. Cell, (20020000), vol. 10, pages 721 - 733
    - TANG, V.W., "Proteomic and bioinformatic analysis of epithelial tight junction reveals an unexpected cluster of synaptic molecules", Biology direct, (20060000), vol. 1, doi:doi:10.1186/1745-6150-1-37, page 37, XP021025702

DOI:   http://dx.doi.org/10.1186/1745-6150-1-37
    - GIANNONI, E.; FIASCHI, T.; RAMPONI, G.; CHIARUGI, P., "Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals", Oncogene, (20090000), vol. 28, pages 2074 - 2086
    - AGGARWAL, B.B.; GEHLOT, P., "Inflammation and cancer: how friendly is the relationship for cancer patients?", Curr Opin Pharmacol, (20090000), vol. 9, doi:doi:10.1016/j.coph.2009.06.020, pages 351 - 369, XP026587067

DOI:   http://dx.doi.org/10.1016/j.coph.2009.06.020
    - TAN, S.H.; PAL, M.; TAN, M.J.; WONG, M.H.L.; TAM, F.U.; TEO, J.W.T.; CHONG, H.C.; TAN, C.K.; GOH, Y.Y.; TANG, M.B.Y., "Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor", J Biol Chem, vol. 284, pages 18047 - 18058
    - AKRAM, S.; TEONG, H.; FLIEGEL, L.; PERVAIZ, S.; CLEMENT, M., "Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers", Cell Death Differ, (20060000), vol. 13, pages 628 - 641
    - BELANGER, A.J.; LU, H.; DATE, T.; LIU, L.X.; VINCENT, K.A.; AKITA, G.Y.; CHENG, S.H.; GREGORY, R.J.; JIANG, C., "Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor lalpha", J Mol Cell Cardiol, (20020000), vol. 34, doi:doi:10.1006/jmcc.2002.2021, pages 765 - 774, XP008051648

DOI:   http://dx.doi.org/10.1006/jmcc.2002.2021
    - BOUILLET, P.; STRASSER, A., "BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death", J Cell Sci, (20020000), vol. 115, pages 1567 - 1574, XP002972061
    - BRIDGE, A.J.; PEBERNARD, S.; DUCRAUX, A.; NICOULAZ, A.L.; IGGO, R., "Induction of an interferon response by RNAi vectors in mammalian cells", Nat Genet, (20030000), vol. 34, doi:doi:10.1038/ng1173, pages 263 - 264, XP002251051

DOI:   http://dx.doi.org/10.1038/ng1173
    - CAZES, A.; GALAUP, A.; CHOMEL, C.; BIGNON, M.; BRECHOT, N.; LE JAN, S.; WEBER, H.; CORVOL, P.; MULLER, L.; GERMAIN, S. et al., "Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton", Circ Res, (20060000), vol. 99, pages 1207 - 1215
    - CHANCE, B.; SIES, H.; BOVERIS, A., "Hydroperoxide metabolism in mammalian organs", Physiol Rev, (19790000), vol. 59, pages 527 - 605
    - CHIARUGI, P., "From anchorage dependent proliferation to survival: lessons from redox signalling", IUBMB Life, (20080000), vol. 60, pages 301 - 307
    - CHIARUGI, P.; FIASCHI, T., "Redox signalling in anchorage-dependent cell growth", Cell Signal, (20070000), vol. 19, doi:doi:10.1016/j.cellsig.2006.11.009, pages 672 - 682, XP005897557

DOI:   http://dx.doi.org/10.1016/j.cellsig.2006.11.009
    - CLEMENT, M.; PERVAIZ, S., "Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death", Redox Rep, (20010000), vol. 6, pages 211 - 214
    - DESGROSELLIER, J.S.; CHERESH, D.A., "Integrins in cancer: biological implications and therapeutic opportunities", Nat Rev Cancer, (20100000), vol. 10, doi:doi:10.1038/nrc2748, pages 9 - 22, XP055016659

DOI:   http://dx.doi.org/10.1038/nrc2748
    - EBLE, J.A.; HAIER, J., "Integrins in cancer treatment", Curr Cancer Drug Targets, (20060000), vol. 6, pages 89 - 105
    - FERRARO, D.; CORSO, S.; FASANO, E.; PANIERI, E.; SANTANGELO, R.; BORRELLO, S.; GIORDANO, S.; PANI, G.; GALEOTTI, T., "Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS", Oncogene, (20060000), vol. 25, pages 3689 - 3698
    - FIDLER, I.J., "Critical determinants of cancer metastasis: rationale for therapy", Cancer Chemother Pharmacol, (19990000), vol. 43, pages S3 - 10
    - GALAUP, A.; CAZES, A.; LE JAN, S.; PHILIPPE, J.; CONNAULT, E.; LE COZ, E.; MEKID, H.; MIR, L.M.; OPOLON, P.; CORVOL, P. et al., "Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness", Proc Natl Acad Sci U S A, (20060000), vol. 103, doi:doi:10.1073/pnas.0609025103, pages 18721 - 18726, XP002576800

DOI:   http://dx.doi.org/10.1073/pnas.0609025103
    - GE, H.; YANG, G.; HUANG, L.; MOTOLA, D.L.; POURBAHRAMI, T.; LI, C., "Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4", J Biol Chem, (20040000), vol. 279, pages 2038 - 2045
    - GIANNONI, E.; BURICCHI, F.; GRIMALDI, G.; PARRI, M.; CIALDAI, F.; TADDEI, M.L.; RAUGEI, G.; RAMPONI, G.; CHIARUGI, P., "Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival", Cell Death Differ, (20080000), vol. 15, pages 867 - 878
    - HANAHAN, D.; WEINBERG, R.A., "The hallmarks of cancer", Cell, (20000000), vol. 100, pages 57 - 70, XP055447752
    - IRANI, K.; XIA, Y.; ZWEIER, J.L.; SOLLOTT, S.J.; DER, C.J.; FEARON, E.R.; SUNDARESAN, M.; FINKEL, T.; GOLDSCHMIDT-CLERMONT, P.J., "Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts", Science, (19970000), vol. 275, pages 1649 - 1652
    - ITO, Y.; OIKE, Y.; YASUNAGA, K.; HAMADA, K.; MIYATA, K.; MATSUMOTO, S.I.; SUGANO, S.; TANIHARA, H.; MASUHO, Y.; SUDA, T., "Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4", Cancer Res, (20030000), vol. 63, pages 6651 - 6657, XP002373803
    - JONESON, T.; BAR-SAGI, D., "A Racl effector site controlling mitogenesis through superoxide production", J Biol Chem, (19980000), vol. 273, pages 17991 - 17994
    - KERSTEN, S.; MANDARD, S.; TAN, N.S.; ESCHER, P.; METZGER, D.; CHAMBON, P.; GONZALEZ, F.J.; DESVERGNE, B.; WAHLI, W., "Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene", J Biol Chem, (20000000), vol. 275, doi:doi:10.1074/jbc.M004029200, pages 28488 - 28493, XP002217322

DOI:   http://dx.doi.org/10.1074/jbc.M004029200
    - KOMATSU, D.; KATO, M.; NAKAYAMA, J.; MIYAGAWA, S.; KAMATA, T., "NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression", Oncogene, (20080000), vol. 27, pages 4724 - 4732
    - KOSTER, A.; CHAO, Y.; MOSIOR, M.; FORD, A.; GONZALEZ-DEWHITT, P.; HALE, J.; LI, D.; QIU, Y.; FRASER, C.; YANG, D., "Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl regulation of triglyceride metabolism", Endocrinology, (20050000), vol. 146, no. 3, doi:doi:10.1210/EN.2005-0476, pages 4943 - 4950, XP002416691

DOI:   http://dx.doi.org/10.1210/EN.2005-0476
    - LE, J.; AMY, C.; CAZES, A.; MONNOT, C.; LAMANDE, N.; FAVIER, J.; PHILIPPE, J.; SIBONY, M.; GASC, J.; CORVOL, P. et al., "Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma", Am J Pathol, (20030000), vol. 162, pages 1521 - 1528, XP002377971
    - LEWIS, A.M.; VARGHESE, S.; XU, H.; ALEXANDER, H.R., "Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment", J Transl Med, (20060000), vol. 4, doi:doi:10.1186/1479-5876-4-48, page 48, XP055494595

DOI:   http://dx.doi.org/10.1186/1479-5876-4-48
    - LI, C., "Genetics and regulation of angiopoietin-like proteins 3 and 4", Curr.Opin.Lipidol., (20060000), vol. 17, doi:doi:10.1097/01.mol.0000217896.67444.05, pages 152 - 156, XP009077842

DOI:   http://dx.doi.org/10.1097/01.mol.0000217896.67444.05
    - LIOU, G.Y.; STORZ, P., "Reactive oxygen species in cancer", Free Radic Res, (20100000), vol. 44, doi:doi:10.3109/10715761003667554, pages 479 - 496, XP055289545

DOI:   http://dx.doi.org/10.3109/10715761003667554
    - MACFARLANE, P.M.; SATRIOTOMO, I.; WINDELBORN, J.A.; MITCHELL, G.S., "NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation", J Physiol, (20090000), vol. 587, pages 1931 - 1942
    - MINN, A.J.; GUPTA, G.P.; SIEGEL, P.M.; BOS, P.D.; SHU, W.; GIRI, D.D.; VIALE, A.; OLSHEN, A.B.; GERALD, W.L.; MASSAGUE, J., "Genes that mediate breast cancer metastasis to lung", Nature, (20050000), vol. 436, doi:doi:10.1038/nature03799, pages 518 - 524, XP002454668

DOI:   http://dx.doi.org/10.1038/nature03799
    - MUELLER, M.M.; PETER, W.; MAPPES, M.; HUELSEN, A.; STEINBAUER, H.; BOUKAMP, P.; VACCARIELLO, M.; GARLICK, J.; FUSENIG, N.E., "Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor", Am J Pathol, (20010000), vol. 159, pages 1567 - 1579
    - MURPHY, G.J.; HOLDER, J.C., "PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer", Trends Pharmacol Sci, (20000000), vol. 21, doi:doi:10.1016/S0165-6147(00)01559-5, pages 469 - 474, XP004226378

DOI:   http://dx.doi.org/10.1016/S0165-6147(00)01559-5
    - MUNZEL, T.; AFANAS'EV, I.B.; KLESCHYOV, A.L.; HARRISON, D.G., "Detection of superoxide in vascular tissue", Arterioscler Thromb Vasc Biol, (20020000), vol. 22, pages 1761 - 1768
    - OBERLEY, L.W., "Anticancer therapy by overexpression of superoxide dismutase", Antioxid Redox Signal, (20010000), vol. 3, pages 461 - 472
    - OIKE, Y.; AKAO, M.; KUBOTA, Y.; SUDA, T., "Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy", Trends Mol Med, (20050000), vol. 11, doi:doi:10.1016/j.molmed.2005.08.002, pages 473 - 479, XP005104728

DOI:   http://dx.doi.org/10.1016/j.molmed.2005.08.002
    - PADUA, D.; ZHANG, X.H.F.; WANG, Q.; NADAL, C.; GERALD, W.L.; GOMIS, R.R.; MASSAGUE, J., "TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4", Cell, (20080000), vol. 133, doi:doi:10.1016/j.cell.2008.01.046, pages 66 - 77, XP055142791

DOI:   http://dx.doi.org/10.1016/j.cell.2008.01.046
    - PAFFENHOLZ, R.; BERGSTROM, R.A.; PASUTTO, F.; WABNITZ, P.; MUNROE, R.J.; JAGLA, W.; HEINZMANN, U.; MARQUARDT, A.; BAREISS, A.; LAU, "Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase", Genes Dev, (20040000), vol. 18, doi:doi:10.1101/gad.1172504, pages 486 - 491, XP002293909

DOI:   http://dx.doi.org/10.1101/gad.1172504
    - PANI, G.; GIANNONI, E.; GALEOTTI, T.; CHIARUGI, P., "Redox-based escape mechanism from death: the cancer lesson", Antioxid Redox Signal, (20090000), vol. 11, pages 2791 - 2806
    - PANIGRAHY, D.; HUANG, S.; KIERAN, M.W.; KAIPAINEN, A., "PPARgamma as a therapeutic target for tumor angiogenesis and metastasis", Cancer Biol Ther, (20050000), vol. 4, pages 687 - 693
    - PERVAIZ, S.; CLEMENT, M.V., "Superoxide anion: oncogenic reactive oxygen species?", Int J Biochem Cell Biol, (20070000), vol. 39, doi:doi:10.1016/j.biocel.2007.04.007, pages 1297 - 1304, XP022145769

DOI:   http://dx.doi.org/10.1016/j.biocel.2007.04.007
    - PERVAIZ, S.; CLEMENT, M.V., "A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification", Biochem Biophys Res Commun, (20020000), vol. 290, pages 1145 - 1150
    - PERVAIZ, S.; RAMALINGAM, J.K.; HIRPARA, J.L.; CLEMENT, M.V., "Superoxide anion inhibits drug-induced tumor cell death", FEBS Lett, (19990000), vol. 459, doi:doi:10.1016/S0014-5793(99)01258-2, pages 343 - 348, XP004375857

DOI:   http://dx.doi.org/10.1016/S0014-5793(99)01258-2
    - PETERS, J.M.; GONZALEZ, F.J., "Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer", Biochim Biophys Acta, (20090000), vol. 1796, pages 230 - 241
    - SALMON, S.E., "Human tumor colony assay and chemosensitivity testing", Cancer Treat Rep, (19840000), vol. 68, pages 117 - 125
    - SHE, Q.B.; SOLIT, D.B.; YE, Q; O'REILLY, K.E.; LOBO, J.; ROSEN, N., "The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells", Cancer Cell, (20050000), vol. 8, doi:doi:10.1016/j.ccr.2005.09.006, pages 287 - 297, XP007920194

DOI:   http://dx.doi.org/10.1016/j.ccr.2005.09.006
    - SHIBANUMA, M.; KUROKI, T.; NOSE, K., "Superoxide as a signal for increase in intracellular pH", J Cell Physiol, (19880000), vol. 136, pages 379 - 383
    - SINGH, S.; SADANANDAM, A.; SINGH, R.K., "Chemokines in tumor angiogenesis and metastasis", Cancer Metastasis Rev, (20070000), vol. 26, doi:doi:10.1007/s10555-007-9068-9, pages 453 - 467, XP019549270

DOI:   http://dx.doi.org/10.1007/s10555-007-9068-9
    - SUH, Y.A.; ARNOLD, R.S.; LASSEGUE, B.; SHI, J.; XU, X.; SORESCU, D.; CHUNG, A.B.; GRIENDLING, K.K.; LAMBETH, J.D., "Cell transformation by the superoxide-generating oxidase Moxl", Nature, (19990000), vol. 401, doi:doi:10.1038/43459, pages 79 - 82, XP002233584

DOI:   http://dx.doi.org/10.1038/43459
    - SUKONINA, V.; LOOKENE, A.; OLIVECRONA, T.; OLIVECRONA, G., "Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue", Proc Natl Acad Sci U S A, (20060000), vol. 103, pages 17450 - 17455
    - SUN, Y.; LODISH, H.F., "Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration", PloS one, (20100000), vol. 5
    - THANNICKAL, V.J.; FANBURG, B.L., "Reactive oxygen species in cell signaling", Am J Physiol Lung Cell Mol Physiol, (20000000), vol. 279, pages L1005 - L1028, XP003011373
    - USHIO-FUKAI, M.; NAKAMURA, Y., "Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy", Cancer Lett, (20080000), vol. 266, doi:doi:10.1016/j.canlet.2008.02.044, pages 37 - 52, XP022697311

DOI:   http://dx.doi.org/10.1016/j.canlet.2008.02.044
    - VERINE, J.; LEHMANN-CHE, J.; SOLIMAN, H.; FEUGEAS, J.P.; VIDAL, J.S.; MONGIAT-ARTUS, P.; BELHADJ, S.; PHILIPPE, J.; LESAGE, M.; WI, "Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma", PloS one, (20100000), vol. 5, doi:doi:10.1371/journal.pone.0010421, page e10421, XP055333343

DOI:   http://dx.doi.org/10.1371/journal.pone.0010421
    - WAGNER, B.A.; EVIG, C.B.; RESZKA, K.J.; BUETTNER, G.R.; BURNS, C.P., "Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells", Arch Biochem Biophys, (20050000), vol. 440, doi:doi:10.1016/j.abb.2005.06.015, pages 181 - 190, XP005027271

DOI:   http://dx.doi.org/10.1016/j.abb.2005.06.015
    - WAGNER, K.D.; WAGNER, N., "Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions", Pharmacol Ther, (20100000), vol. 125, doi:doi:10.1016/j.pharmthera.2009.12.001, pages 423 - 435, XP026917084

DOI:   http://dx.doi.org/10.1016/j.pharmthera.2009.12.001
    - WANG, Y.; LAM, K.S.L.; LAM, J.B.B.; LAM, M.C.; LEUNG, P.T.Y.; ZHOU, M.; XU, A., "Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice", Mol Endocrinol, (20070000), vol. 21, pages 972 - 986
    - WANG, Z.; HAN, B.; ZHANG, Z.; PAN, J.; XIA, H., "Expression of angiopoietin- like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma", Biomarkers, (20100000), vol. 15, pages 39 - 46
    - WERNER, E.; WERB, Z., "Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases", J Cell Biol, (20020000), vol. 158, pages 357 - 368
    - WESTHOFF, M.A.; FULDA, S., "Adhesion-mediated apoptosis resistance in cancer", Drug Resist Updat, (20090000), vol. 12, doi:doi:10.1016/j.drup.2009.08.001, pages 127 - 136, XP026681857

DOI:   http://dx.doi.org/10.1016/j.drup.2009.08.001
    - WU, W.S., "The signaling mechanism of ROS in tumor progression", Cancer Metastasis Rev, (20060000), vol. 25, pages 695 - 705, XP019464217
    - ZHAN, M.; ZHAO, H.; HAN, Z.C., "Signalling mechanisms of anoikis", Histol Histopathol, (20040000), vol. 19, pages 973 - 983
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.